| Apellido | ERNST |
| Nombre | DANIEL |
| ID | 7914747 |
"Su solicitud se enviará en seg. Por favor espere."
SUGERENCIAS
ERNST-DIAZ, DANIEL MATIAS Autor ID: 422446 ver autor
Articulos ( 30 en total, se muestran 3 )
● Acute Myeloblastic Leukemia in Chile. Treatment and Outcomes in Patients Admitted at the Hospital Clinico De La Pontificia Universidad Catolica De Chile Between 2010-2014, 2014
● Admission of Hematopoietic Cell Transplantation Patients to the Intensive Care Unit at the Pontificia Universidad Católica de Chile Hospital, 2015
● Allogeneic Hematopoietic Stem Cell Transplantation (aHSCT) In Adult Patients With Acute Lymphoblastic Leukemia (ALL): Experience Of The Hematology-Oncology Department At Pontificia Universidad Catolica De Chile Between 1994 and 2013, 2014
Afiliaciones ( 9 en total, se muestran 3 )
● Clínica Alemana
● Escuela de Medicina
● Facultad de Medicina
Ernst, Daniel Autor ID: 6583821 ver autor
Articulos ( 1 en total )
● Integration of T-cell clonality screening using TRBC-1 in lymphoma suspect samples by flow cytometry, 2024
Afiliaciones ( 2 en total )
● Clínica Alemana
● Universidad del Desarrollo
Ernst, D. M. Autor ID: 7712055 ver autor
Articulos ( 1 en total )
● 17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023, 2023
Afiliaciones ( 1 en total )
● Clínica Alemana
Ernst, Daniel Autor ID: 8586173 ver autor
Articulos ( 1 en total )
● Zilovertamab Vedotin Monotherapy for Patients with Relapsed or Refractory Mantle Cell Lymphoma: Cohort a of the Multicenter, Open-Label, Phase 2 Waveline-006 Study, 2024
Afiliaciones ( 1 en total )
● Clínica Alemana
ÁREA DE TRABAJO
FIRMA SELECCIONADA COMO BASE
Ernst, Daniel Autor ID: 7914747 ver autor
Articulos ( 1 en total )
● Zilovertamab Vedotin (ZV) Alone or in Combination With Nemtabrutinib in Relapsed or Refractory (R/R) Aggressive and Indolent B-Cell Malignancies (waveLINE-006): An Open-Label, Phase 2 Basket Study, 2024
Afiliaciones ( 1 en total )
● Clínica Alemana
FIRMAS SELECCIONADAS PARA AGRUPAR